The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cutting Edge: CpG Oligodeoxynucleotides Trigger Protective and Curative Th1 Responses in Lethal Murine Leishmaniasis
Open accessAbstract
Synthetic oligodeoxynucleotides containing CpG dinucleotides (CpG-ODN) mimic the immunostimulatory qualities of bacterial DNA. We asked whether immunostimulation by CpG-ODN predisposes for a commitment toward a Th1 vs a Th2 response in Leishmania major infection, a model for a lethal Th2-driven disease, in BALB/c mice. CpG-ODN induced Th1 effector T cells in vitro and conveyed protective immunity to disease-prone BALB/c mice in vivo. Conversion to a Th1-driven resistant phenotype was associated with IL-12 production and maintained the expression of IL-12R β2-chains. Most strikingly, CpG-ODN were even curative when given as late as 20 days after lethal L. major infection, indicating that CpG-ODN revert an established Th2 response. These findings imply an important role of bacterial DNA and CpG-ODN in the instruction of adaptive immune responses. They also point to the therapeutic potential of CpG-ODN in redirecting curative Th1 responses in Th2-driven disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
The Regulation of Immunity to Leishmania major
Reiner, S. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.151 · Cited by 1,297
Altered immune responses in mice lacking inducible nitric oxide synthase
Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Mullers, W., Moncada, S., & Liew, F. Y. (1995) · Nature · doi:10.1038/375408a0 · Cited by 1,292
Szabo, S. J., Dighe, A. S., Gubler, U., & Murphy, K. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.817 · Cited by 1,005
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
Recombinant interleukin 12 cures mice infected with Leishmania major.
Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1505 · Cited by 761
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1797 · Cited by 720
Scott, P., Natovitz, P., Coffman, R. L., Pearce, E., & Sher, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1675 · Cited by 705
Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., & Locksley, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.115 · Cited by 620
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
DNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Sparwasser, T., Koch, E.-S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., & Wagner, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<2045::aid-immu2045>3.0.co;2-8 · Cited by 794
Self-citationHäcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
Self-citationCpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
Hartmann, G., Weiner, G. J., & Krieg, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9305 · Cited by 626
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605
Leishmaniasis: Current Status of Vaccine Development
Handman, E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.229-243.2001 · Cited by 600
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Hochrein, H., O'Keeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskovsky, E., & Shortman, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.823 · Cited by 368
The role of CpG motifs in innate immunity
Krieg, A. M. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00048-5 · Cited by 343
Limiting inflammatory responses during activation of innate immunity
Han, J., & Ulevitch, R. J. (2005) · Nature Immunology · doi:10.1038/ni1274 · Cited by 315
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
Self-citationElkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., & Klinman, D. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2291 · Cited by 314
Can innate immunity be enhanced to treat microbial infections?
Finlay, B. B., & Hancock, R. E. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro908 · Cited by 298
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice
Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P., Levine, A. D., et al. (2001) · Nature Immunology · doi:10.1038/ni725 · Cited by 294
Self-citationIsraeli, E., Agmon-Levin, N., Blank, M., & Shoenfeld, Y. (2009) · Lupus · doi:10.1177/0961203309345724 · Cited by 271
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
DNA vaccines: a key for inducing long-term cellular immunity
Gurunathan, S., Wu, C.-Y., Freidag, B. L., & Seder, R. A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00118-7 · Cited by 261
Postexposure prophylaxis against prion disease with a stimulator of innate immunity.
Sethi, S., Lipford, G., Wagner, H., & Kretzschmar, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09513-2 · Cited by 138
Self-citationSpinner, D. S., Kascsak, R. B., LaFauci, G., Meeker, H. C., Ye, X., Flory, M. J., Kim, J. I., Schuller-Levis, G. B., Levis, W. R., Wisniewski, T., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106665 · Cited by 54
Metadata
- Authors
- Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Röcken, M., Wagner, H., & Heeg, K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-04
- Volume
- 160
- Issue
- 8
- Pages
- 3627-3630
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313342408
- Cited by
- 367
- References
- 27
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.